| Original language | English |
|---|---|
| Pages (from-to) | 33393-33404 |
| Number of pages | 12 |
| Journal | Oncotarget |
| Volume | 8 |
| Issue number | 20 |
| DOIs | |
| Publication status | Published - 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Austrian Fields of Science 2012
- 301207 Pharmaceutical chemistry
Keywords
- Journal Article
- CELLS
- gene therapy
- EGFR-targeting
- sodium iodide symporter
- genetically engineered mouse model
- pancreatic ductal adenocarcinoma
- LIVER-CANCER
- GROWTH-FACTOR RECEPTOR
- INHIBITION
- RADIOIODINE THERAPY
- MOUSE MODEL
- PROSTATE-CANCER
- HEPATOCELLULAR CANCER
- SYSTEMIC NONVIRAL DELIVERY
- EGF RECEPTOR
- Genetically engineered mouse model
- Pancreatic ductal adenocarcinoma
- Sodium iodide symporter
- Gene therapy
Fingerprint
Dive into the research topics of 'Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver